As global demand for agile, high-quality vaccine development continues to surge, the role of Contract Development and Manufacturing Organizations (CDMOs) has never been more vital. With increasing emphasis on mRNA, DNA, recombinant protein, and viral vector-based platforms, biopharmaceutical innovators are turning to specialized partners to accelerate time-to-market while maintaining strict regulatory compliance.
Litchlab is proud to lead this evolution with a dedicated vaccine development platform tailored for nucleic acid and lipid-based delivery systems. Backed by cutting-edge formulation science, advanced manufacturing infrastructure, and deep regulatory insight, we offer end-to-end CDMO services that enable rapid and reliable vaccine development — from discovery to GMP batch release.
1️⃣ Lipid-based Delivery Platforms
Litchlab specializes in the design and production of lipid nanoparticles (LNPs) and cationic liposomes optimized for the encapsulation and delivery of mRNA, saRNA, and plasmid DNA vaccines. These delivery systems ensure high stability, effective cellular uptake, and robust immunogenicity.
2️⃣ Formulation & Process Development
Nucleic acid-lipid complexation
Microfluidic-based mixing for LNPs
Cryoprotectant screening and lyophilization
Scalability from benchtop to GMP clinical lots
3️⃣ Analytical & Regulatory Support
Particle size, zeta potential, and encapsulation efficiency
Stability testing under ICH guidelines
Regulatory documentation support for IND, CTA, and NDA submissions (FDA, EMA, NMPA)
The CDMO sector is witnessing a global expansion in vaccine outsourcing, driven by:
Rising demand for nucleic acid vaccine platforms post-COVID
Urgent development of pandemic preparedness pipelines
Growing focus on personalized cancer vaccines and rare disease immunotherapies
Need for flexible and modular GMP production infrastructure
In this dynamic context, Litchlab’s comprehensive capabilities in nucleic acid delivery, lyophilization, and regulatory support are strategically positioned to support biotech and pharmaceutical innovators around the world.
✔️ Proven track record in LNP and liposome delivery
✔️ Fully integrated CDMO workflow for rapid timelines
✔️ Specialized in nucleic acid vaccine platforms
✔️ GMP facilities ready for clinical-grade production
✔️ Global regulatory and tech-transfer experience
📞 Discover more:
👉 Visit: www.litchlab.com
📧 Contact: Sales@litchlab.com
